Search results
Redistribution of garbage codes to underlying causes of death: a systematic analysis on Italy and a comparison with most populous Western European countries based on the Global Burden of Disease Study 2019
The proportion of reported causes of death that are not underlying causes can be relevant even in high-income countries and seriously affect health planning. The Global Burden of Disease (GBD) study identifies these 'garbage codes' and redistributes them to underlying causes using evidence-based algorithms.
Endline assessment of a community-based program on hypertension and diabetes management in Brazil
In this independent prospective evaluation, we used both quantitative and qualitative data to assess the potential impact of the Brazil HealthRise programs on improving clinical and health outcomes for hypertension and diabetes patients in Teófilo Otoni and Vitoria da Conquista. We hypothesized that participation in the Brazil HealthRise program could lead to reduced biomarker readings and increase the proportion of individuals meeting treatment targets for both conditions.
Measuring the availability of human resources for health and its relationship to universal health coverage: estimates for 204 countries and territories from 1990 to 2019
We aimed to use comparable and standardised data sources to estimate human resources for health (HRH) densities globally, and to examine the relationship between a subset of HRH cadres and UHC effective coverage performance.
Current dichotomous metrics obscure trends in severe and extreme child growth failure
Our analysis presents the first ever estimates of entire distributions of stunting, wasting, and underweight for each of 204 countries and territories from 1990 to 2020 for children less than 5 years old by age group and sex.
Vaccines and the social amplification of risk
The trends in vaccine confidence and resistance have implications for updating the social amplification of risk framework (SARF); in turn, SARF has practical implications for guiding efforts to alleviate vaccine hesitancy and to mitigate harms from intentional and unintentional vaccine scares.
Estimated health outcomes and costs of COVID-19 prophylaxis with monoclonal antibodies among unvaccinated household contacts in the US
We aimed to estimate the health outcomes and net cost of implementing postexposure prophylaxis (PEP) with monoclonal antibodies (mAbs) against household exposure to COVID-19.
Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis
In this study, we aimed to provide a novel approach to estimating past SARS-CoV-2 infections, combining data from reported cases, reported deaths, excess deaths attributable to COVID-19, hospitalizations, and seroprevalence surveys
Cost-effectiveness of Vitamin A supplementation among children in three sub-Saharan African countries: An individual-based simulation model using estimates from Global Burden of Disease 2019
In this study, we conducted a cost-effectiveness analysis of a Vitamin A Supplementation scale-up in Nigeria, Kenya, and Burkina Faso.
Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
We examined the temporal patterns of the global, regional, and national burden of colorectal cancer and its risk factors in 204 countries and territories across the past three decades.
Health system performance in Iran: a systematic analysis for the Global Burden of Disease Study 2019
In this systematic analysis, we present the national and subnational estimates of the burden of disease in Iran using the Global Burden of Disease Study 2019.
Injury burden in individuals aged 50 years or older in the Eastern Mediterranean region, 1990–2019
We aimed to examine injury-related morbidity and mortality among adults aged 50 years or older in 22 Eastern Mediterranean countries.
The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990–2019: Findings from the Global Burden of Disease Study 2019
We estimated the burden of mental disorders, substance use disorders, and self-harm in people aged 10-24 in 31 European countries.
Burden of non-communicable diseases among adolescents aged 10–24 years in the EU, 1990–2019: a systematic analysis of the Global Burden of Diseases Study 2019
NCD-related mortality has substantially declined among adolescents in the EU between 1990 and 2019, but the rising trend of YLL attributed to mental disorders and their YLD burden are concerning.
Population health outcomes in Nigeria compared with other west African countries, 1998–2019: a systematic analysis for the Global Burden of Disease Study
We undertook a comprehensive assessment of the burden of disease in Nigeria and compared outcomes to other west African countries.
Progress in health among regions of Ethiopia, 1990–2019: a subnational country analysis for the Global Burden of Disease Study 2019
The GBD 2019 Ethiopia subnational analysis aimed to measure the progress and disparities in health across nine regions and two chartered cities.
Global and regional spending on dementia care from 2000–2019 and expected future health spending scenarios from 2020–2050: An economic modelling exercise
We modelled healthcare spending attributable to dementia from 2000 to 2019 and expected estimated future spending from 2020 to 2050 under multiple scenarios.
Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21
Mortality statistics are fundamental to public health decision making. Mortality varies by time and location, and its measurement is affected by well known biases that have been exacerbated during the COVID-19 pandemic. This paper aims to estimate excess mortality from the COVID-19 pandemic in 191 countries and territories, and 252 subnational units for selected countries, from Jan 1, 2020, to Dec 31, 2021.
Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study
We used data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD 2019) to estimate mortality and disability trends for the population aged ≥70 and evaluate patterns in causes of death, disability, and risk factors.
Quantifying the effects of the COVID-19 pandemic on gender equality in health, social, and economic indicators
Gender is emerging as a significant factor in the social, economic, and health effects of COVID-19; yet most existing studies have focused on its direct impact on health. Here we explore the indirect effects of COVID-19 on gender disparities globally.
Variation in the COVID-19 infection–fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis
The infection–fatality ratio (IFR) is a metric that quantifies the likelihood of an individual dying once infected with a pathogen. Understanding the determinants of IFR variation for COVID-19, the disease caused by the SARS-CoV-2 virus, has direct implications for mitigation efforts with respect to clinical practice, non-pharmaceutical interventions, and the prioritisation of risk groups for targeted vaccine delivery.
Supplement to the European Health Report 2021: Projections for a selection of indicators for health-related Sustainable Development Goals
The European Health Report is produced every three years by the WHO Regional Office for Europe, providing insight into the Regional progress towards health-related SDGs.